Rheedia gardneriana, GB2a Derivative. Analgesia This paper describes the isolation, identification and analgesic activity of a new biflavonoid from Rheedia gardneriana leaves, which correspond to I3-naringenin-II8-4'-OMe-eriodictyol (GB-2a-II-4'-OMe) (1). with a methoxyl group in position 4 of ring-II. Its structure was determined by spectroscopic data and confirmed by an alkaline hydrolysis. Its analgesic effect was evaluated in a writhing test and a formalin test in mice. It was found that this compound exhibits potent and dose-related analgesic action in both experimental models, with ID 50 's values of 4.5 [.imol/kg against the writhing test and 8.2 and 6.8 [.imol/kg against the first and second phase of the formalin test, respectively. It was several times more potent than some well-known analgesic drugs used as reference.
Introduction
We have previously demonstrated that some biflavonoids extracted from Rheedia gardneriana leaves, a Brazilian medicinal plant, exhibit analge sic effects in mice. Such compounds, denoted volkensiflavone, I3-naringenin-II8-eriodictyol (GB2a), fukugetin and fukugiside, were isolated from the ethyl acetate fraction, and caused significative analgesic action in relation to the second phase (inflammatory pain) of the formalin test (Luzzi et a l., 1997) . In a recent study, we have also shown that another biflavonoid isolated from Clusia colunmaris , known as G B la, presented potent and dose-related analgesic activity when evaluated in different models of pain in mice (Bittar et al., 2000) .
In this study we have extended our previous findings with the R. gardneriana leaves, with the isolation of a new biflavonoid, which was analysed as analgesic or antinociceptive on chemical and thermal models of nociception in mice. Further more. the results of some reference drugs were in cluded for the purpose of comparison.
M aterial and Methods

Plant material
The leaves of R. gardneriana PI. Tr. (Guttiferae) were collected from a population growing on the outskirts of FURB, in Blumenau city, in Decem ber, 1995. The plant was identified by Prof. Marcos Sobral (Departamento de Botanica, Universidade Federal do Rio Grande do Sul, Porto Alegre) and the vouchers were deposited in Dr. Roberto M i guel Klein Herbarium (Departamento de Ciencias Naturais, FURB, Blumenau) under numbers 534 to 540.
Isolation and identification o f biflavonoids
Air dried leaves (150 g) of R. gardneriana were powdered and macerated with 50% ethanol (1.2 1) at room temperature for approximately 15 days. After solvent removal, the extract was succesively partitioned with hexane, chloroform, ethyl acetate and butanol, respectively.
Ethyl acetate fraction (3.75 g) was chromato graphed on a silica gel column eluted with 0939-5075/2000/0900-0820 $ 06.00 © 2000 Verlag der Zeitschrift für Naturforschung, Tübingen • www.znaturforsch.com • D CHCl3:MeOH gradient, giving four biflavonoids: volkensiflavone (55 mg), GB2a (2) (141 mg), fukugetin (810 mg) and fukugiside (100 mg) as pre viously described (Luzzi et al., 1997) . In the course of the experimental procedure, a minor fraction (FI, 60 mg) was also obtained, which gave positive test with FeCl3 reagent in TLC, indicating the presence of a different phenolic compound. The R f value was different from those biflavonoids cited earlier. FI was then rechromatographed as in the previous case, giving a pure yellow solid (25 mg, mp= 230-3 °C) which was identified as I3-naringenin-II8-4'-OMe-eriodictyol (GB2a-II-4'-OMe) (1) on the basis of its spectroscopic data ('H-and 13C-NMR) in comparison with GB2a (2) ( Table I) .
Pharm acological analysis W rithing test
Male Swiss mice (25-30 g) were used. The ab dominal constriction induced by intraperitoneal injection of acetic acid (0.6%), was carried out ac cording to the procedures described previously (Collier et al., 1968; Souza et al., 1998) with minor modifications. The animals were pretreated with compound 1 intraperitoneally (1.75 to 17.5 pmol/ kg) 30 min before the acid acetic injection. Control animals received a similar volume of 0.9% NaCl (10 ml.kg-1 , i.p.). All experiments were carried out at 23 ± 2 °C. After challenge, pairs of mice were placed in separate boxes and the number of abdominal constrictions of the abdominal muscles together with a stretching, were cumulatively counted over a period of 20 min. Antinociceptive activity was expressed as the reduction of the number of abdominal contractions between con trol animals and mice pretreated with the com pound studied.
Formalin-induced pain
The procedure used was essentially similar to that previously described (Hunskaar et al., 1985; Willain Filho et al., 1997) . Animals (25-30 g) from the same strain were slightly anaesthetized with ether, except when used to analyse the first phase of formalin-induced pain, and 20 pi of 2.5% (0.92% formaldehyde) made up PBS (phosphate buffered solution, containing: NaCl 137 m M ; KC1 2.7 m M and phosphate buffer 10 m M ) was injected s.c. under the plantar surface of the left hindpaw with a Hamilton syringe. Animals were acclima tized to the laboratory for at least 24h before ex periments. Two mice (control and treated) were simultaneously observed from 0 up to 30 min following formalin injection. The initial nocicep tive scores normally peaked after 5 min (first phase, representing the neurogenic pain), and 15-30 min after formalin injection (second phase, rep resenting the inflammatory pain) (Hunskaar et al., 1985) . Animals were treated with saline 0.9% (10 ml/kg, i.p.) or with compound 1 (1.75 to 17.5 pmol/kg) 60 min before formalin injection. After intraplantar irritant application, the animals were immediately placed into a glass cylinder (20 cm diameter). The time spent by animals licking or biting the injected paw was timed with a chronom eter and was considered indicative of pain.
Statistical analysis
The results are presented as mean ± s.e.m., and the statistical significance between the groups was analysed by means of an analysis of variance fol lowed by Dunnett's multiple comparison test. P values less than 0.05 were considered as indicative of significance. The ID 50 values (the dose of the compound that reduced responses by 50% in rela tion to control values) were estimated by graphical interpolation from individual experiments. IDsq's are presented as mean values and 95% confidence interval. MI is the maximum inhibition at higher dose used.
Results and Discussion
In our previous study with the R. gardneriana leaves, we isolated four biflavonoids with analgesic properties (Luzzi et al., 1997) . However, we de tected other minor phenolic compound present in the ethyl acetate fraction, which gave positive test with FeCl3 reagent. Considering that the subfrac tion containing this compound exhibited antinoci ceptive action in the writhing test in mice (results not shown), it was submitted for the usual chroma tographic procedures (CC, TLC), giving a pure yellow solid (1). The spectral data of 1 were very similar to those of GB2a (2) ( Table I) previously isolated from the roots of R. gardneriana (Botta et al., 1984) . However, in the 13C-NMR spectrum, 1 (1) R=H, R-Me (2) R=R'=H OH OH O (3) R"= Me (4) R"= H exhibited a signal due to a methoxyl group at 6 55.7 ppm which was confirmed from 'H-NMR spectrum at ö 3.77 ppm, presumably being at tached in ring II. Because of the atropisomerism, a well-known feature of biflavonoids (Häfner and Frahm, 1993; Martinez et al., 1996) , the exact local ization of the methoxyl group in compound 1 re quired additional experiments, such as an alkaline hydrolysis. This was carried out under special con ditions, according to the methodology previously described (Delle Monache et al., 1967) . This pro vided several compounds including 3-hydroxy-4-methoxy benzoic acid (isovanillic acid), which was detected by spectral data and gas chromatography (co-injection) using an authentic sample thus con firming structure 1. Another important confirm ation of this assumption is a comparison of the 13C-NMR spectrum with those of two similar flavanones, hesperitin (3) and eriodictyol (4). The difference in values of C-l' and C-5' (Wagner and Chari, 1976) is very similar to the difference of these carbon atoms in compounds 1 and 2. Table II shows that 1 caused graded and signifi cant inhibition of acetic acid-induced abdominal constriction, with an ID 50 value of 4.5 |j,mol/kg and maximum inhibition of 80 ± 4%. It was about 17 to 36 fold-more active than the standard drugs. In the formalin test, 1 inhibited both phases of pain (Table II) . However, in contrast to the results pre viously shown for other biflavonoids present in R. gardneriana (Luzzi et a l., 1997) , compound 1 pre sented analgesic effects against both the neuro genic (first) and inflammatory (second) phases, but the effect was slightly more pronounced in the late phase of the formalin-induced licking re sponse. The calculated mean ID 50 value for the first phase was 8.2 with maximum inhibition of 62 ± 2%, whereas the ID 50 value for the second phase was 6.8 ^imol/kg, with maximum inhibition of 86 ± 3%. It was about 17 fold-more potent than aspirin and paracetamol against the second phase of the formalin test. The activity of 1 in relation to the first phase of the formalin test indicates that the presence of a methoxyl group in the molecule is important to inhibit the chemical mediators in volved in the neurogenic pain. This could be re lated to the increase of hydrophobicity of the molecule.
To determine whether the antinociceptive activ ity of 1 in formalin-induced pain was related to anti-oedematogenic action, we measured the paw oedema by comparing the difference in weight of the formalin-treated paw and the weight of the control paw (Vaz et al., 1996) . The results showed that the analgesic action of 1 against the second phase of the formalin test is not associated with the paw oedema. Although centrally acting drugs inhibit both phases of the formalin test (Vaz et al., 1996) and peripheral acting drugs only inhibiting the second phase (Table II) , further studies are necessary to elucidate the mechanism of analgesic action of 1.
